| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |